About Dr. Paul MacKoul, MD
Dr. Paul MacKoul, MD, is a leader in the field of Gynecologic surgery. He is a healthcare professional who is focused on providing "Value-Based Care," which means the best Care at the lowest cost. Dr. MacKoul is currently a co-founder of the Center for Innovative GYN Care, which is a leader in the development of "new procedural technology" for freestanding surgery centers. He is also the CEO of Tower Surgical Partners, a company that focuses on the growth and expansion of GYN surgery centers with a single focus.
In any field of surgery, developing new techniques and procedures that will "change the landscape" requires first learning how surgery is done now, then adapting and changing the way surgery is done to get better results. Dr. MacKoul thought it was essential to do a fellowship in gynecological oncology so he could learn how to do surgery as his main focus. GYN Oncology is the highest level of surgical training that can be done in the field. It focuses on how to treat complex gynecological problems and cancers through surgery. Knowing that an OBGYN mainly focuses on obstetrics and not surgery, GYN Oncology training was a great way to prepare for surgery.
After finishing his fellowship, Dr. MacKoul worked with several experienced GYN Oncologists and eventually became the Director of Gynecologic Oncology at Washington Hospital Center (WHC) in Washington, DC. WHC is a massive facility in the middle of the city that had to take Care of a lot of people who didn't have insurance and had challenging medical and social problems. One of the things Dr. MacKoul worked hard on was using laparoscopic surgery, also called "minimally invasive surgery," to avoid making significant open cuts. Patients with cancer and complex surgical problems were able to leave the hospital the same day, recover faster, and start treatment much sooner than if they had had traditional "open" surgery, which was much more painful and took much longer to recover from.
The next step in his career was to become the Director of Gynecological Oncology at the George Washington University Medical Center in downtown Washington, DC. Dr. MacKoul was in charge of minimally invasive gynecological surgery at Holy Cross Hospital in Silver Spring, Maryland, which was part of the GW Medical Center at the time. By teaching residents new techniques and procedures, Dr. MacKoul was able to improve Care for women and cut down on recovery time, pain, complications, and cost.
As the results of surgery got better, Dr. MacKoul started to write about them and talk about them nationally and internationally. Major news outlets like Bloomberg News and HuffPost, as well as CNN, ABC, and KSN, all saw the benefits of the new procedures.
Dr. Paul MacKoul, MD and his partner, Dr. Danilyants, came up with DualportGYN, a specialized surgical technique for treating endometriosis, pelvic masses, and hysterectomy. They then used it on thousands of patients to make sure it worked well and then published it. Comparing robotics, laparoscopic, and vaginal approaches to hysterectomy on more than 2600 patients, DualportGYN had the fastest recovery, fewest complications, and lowest cost of any other type of hysterectomy in the published literature. In fact, DualportGYN saved more than $5,000 compared to another robotic hysterectomy method. Data from DualportGYN was published in a number of major peer-reviewed journals, and the results were talked about at conferences across the country.
Endometriosis was also shown to be very easy to get rid of with DualportGYN. This is called excision. In surgery, DualportGYN uses a powerful method called "retroperitoneal dissection." This method allows for the complete removal of all diseases while fully exposing the area, avoiding damage to nearby structures, and reducing complications by a significant amount. Patients with endometriosis now have a surgery option that is much better and less invasive than multiple incisions with robotics. This surgery can also be done much faster and for much less money.
The LAAM Fibroid surgery, which was also made, was even more revolutionary than DualportGYN. With LAAM fibroid removal surgery, the fibroids were taken out of the uterus, so the uterus could still be used for pregnancy. LAAM didn't need to make a big open cut to remove a fibroid, and they didn't use an expensive and time-consuming Robot to do the job, which would have caused more problems and cost more money. Instead, LAAM only made two cuts and was able to remove fibroids of any size from the entire uterus. All of the patients went home on the same day as the surgery. LAAM was improved over thousands of cases, and a study comparing it to robotics, open surgery, and laparoscopic surgery showed that it had the lowest rate of complications and the fastest recovery time.
LAAM has been shown to remove more fibroids from all parts of the uterus than laparoscopic and robotic surgery while still being safe and effective. LAAM has been talked about at big conferences all over the US.
Dr. MacKoul's two highly effective and powerful surgical approaches to hysterectomy, fibroid removal surgery, and endometriosis, showed that the surgery could be done on an "outpatient" basis, which means that the patients went home the same day as the surgery. The procedures were shown to be safe and effective, and it became clear that there was no reason why they couldn't be done in a surgery center that wasn't attached to a hospital.
Freestanding surgery centers that only do GYN surgery are suitable for both patients and the healthcare system as a whole. Because the surgery center only does GYN surgery, the quality of Care and patient satisfaction are both better. This makes Care better and makes problems less likely to happen. Also, surgery centers that are not attached to hospitals are 60% cheaper than hospitals. This saved a lot of money and added to the savings when DualportGYN and LAAM Fibroids were compared to mechanical or other methods.
Dr. Paul MacKoul, MD opened the first ambulatory surgery center (ASC) in Rockville, Maryland, through Tower Surgical Partners. The second one was in Maryland, and the third was in Secaucus, New Jersey. These ASCs are "state of the art" and have the best equipment and optics. They also have the highest safety profile possible with specially trained staff, "cell savers" that avoid transfusion, the lowest infection rates, and an environment that is very good for the highest quality GYN surgery available.
Value-Based Care has been Dr. MacKoul's primary focus for the whole of his career. With the development of robust and innovative techniques and procedures like DualportGYN and LAAM Fibroid surgery, there are fewer complications, better results, and lower costs. Both DualportGYN and LAAM Fibroids worked well in the ASC setting outside of a hospital because they were safe and worked well. As a result, the surgery "shifted" from the hospital to the freestanding ASC. This made the results even better and cut the costs of the surgery by a considerable amount. Prices that are lower are suitable for patients, doctors, insurance companies, and the health care system as a whole.
All GYN surgeons should learn and create techniques as good as DualportGYN and LAAM Fibroids so that their patients can get the best care possible at the lowest cost. Having these procedures done at freestanding surgery centers helps reach this goal, and Dr. MacKoul's mission is to train doctors in surgery and give patients access to ASCs so that this Value-Based Care approach to GYN surgery can grow.